[S02DA03, antipyrine, Antipyrine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J01GA01, streptomycin, Allopurinol may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[L01AD04, streptozocin, The risk or severity of adverse effects can be increased when Allopurinol is combined with Streptozocin.]
[M04AX02, pegloticase, The risk or severity of adverse effects can be increased when Allopurinol is combined with Pegloticase.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J01CG01, sulbactam, Allopurinol may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, Sulfadiazine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, Allopurinol may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.]
[M04AB02, sulfinpyrazone, The excretion of Sulfinpyrazone can be increased when combined with Allopurinol.]
[M01AB02, sulindac, Sulindac may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[M01AX04, apazone, The excretion of Azapropazone can be increased when combined with Allopurinol.]
[L01BB02, mercaptopurine, The serum concentration of Mercaptopurine can be increased when it is combined with Allopurinol.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01CB02, teniposide, The risk or severity of adverse effects can be increased when Allopurinol is combined with Teniposide.]
[R03CC03, terbutaline, Allopurinol may decrease the excretion rate of Terbutaline which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, Allopurinol may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, The excretion of Allopurinol can be increased when combined with Testosterone.]
[S03AA02, tetracycline, The excretion of Allopurinol can be decreased when combined with Tetracycline.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L04AX02, thalidomide, The risk or severity of adverse effects can be increased when Allopurinol is combined with Thalidomide.]
[R03DA07, theobromine, The serum concentration of Theobromine can be increased when it is combined with Allopurinol.]
[R03DA04, theophylline, The serum concentration of Theophylline can be increased when it is combined with Allopurinol.]
[P02CA02, thiabendazole, Allopurinol may decrease the excretion rate of Thiabendazole which could result in a higher serum level.]
[L01XX41, eribulin, The risk or severity of adverse effects can be increased when Allopurinol is combined with Eribulin.]
[R06AD03, thiethylperazine, Thiethylperazine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01AC01, thiotepa, The risk or severity of adverse effects can be increased when Allopurinol is combined with Thiotepa.]
[L01BB03, thioguanine, The risk or severity of adverse effects can be increased when Allopurinol is combined with Tioguanine.]
[G04BE06, moxisylyte, Allopurinol may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, Allopurinol may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, Ticlopidine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[S01ED01, timolol, Timolol may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[P01AB02, tinidazole, Allopurinol may decrease the excretion rate of Tinidazole which could result in a higher serum level.]
[S01AA12, tobramycin, Allopurinol may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, Allopurinol may decrease the excretion rate of Tolazamide which could result in a higher serum level.]
[V04CA01, tolbutamide, The metabolism of Tolbutamide can be decreased when combined with Allopurinol.]
[M02AA21, tolmetin, Tolmetin may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N02AX02, tramadol, Tramadol may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, Allopurinol may decrease the excretion rate of Triazolam which could result in a higher serum level.]
[C03AA06, trichlormethiazide, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Trichlormethiazide.]
[A16AX12, trientine, Allopurinol may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[S01AD02, trifluridine, Trifluridine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[A03AA05, trimebutine, Allopurinol may decrease the excretion rate of Trimebutine which could result in a higher serum level.]
[J01EA01, trimethoprim, Allopurinol may decrease the excretion rate of Trimethoprim which could result in a higher serum level.]
[R03DX07, roflumilast, Allopurinol may decrease the excretion rate of Roflumilast which could result in a higher serum level.]
[L01FX04, ipilimumab, Allopurinol may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[L01EX04, vandetanib, Vandetanib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[R02AA14, oxyquinoline, Allopurinol may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[J05AG05, rilpivirine, Rilpivirine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[S01AA28, vancomycin, Allopurinol may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, Allopurinol may decrease the excretion rate of Ezogabine which could result in a higher serum level.]
[B01AF01, rivaroxaban, Allopurinol may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C08DA01, verapamil, Allopurinol may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[S01AD06, vidarabine, The metabolism of Vidarabine can be decreased when combined with Allopurinol.]
[N06AX09, viloxazine, Allopurinol may decrease the excretion rate of Viloxazine which could result in a higher serum level.]
[L01CA01, vinblastine, The risk or severity of adverse effects can be increased when Allopurinol is combined with Vinblastine.]
[L01CA03, vindesine, The risk or severity of adverse effects can be increased when Allopurinol is combined with Vindesine.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[B01AA03, warfarin, The risk or severity of bleeding can be increased when Allopurinol is combined with Warfarin.]
[S01AA13, fusidic acid, Fusidic acid may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF01, zidovudine, The risk or severity of adverse effects can be increased when Allopurinol is combined with Zidovudine.]
[L01EC01, vemurafenib, Vemurafenib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[M05BA05, tiludronic acid, Allopurinol may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.]
[B06AC02, icatibant, Allopurinol may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[A02BC04, rabeprazole, Rabeprazole may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Allopurinol may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[L04AA34, alemtuzumab, The risk or severity of adverse effects can be increased when Allopurinol is combined with Alemtuzumab.]
[N02BA01, aspirin, The therapeutic efficacy of Allopurinol can be decreased when used in combination with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, The risk or severity of adverse effects can be increased when Allopurinol is combined with Ruxolitinib.]
[G04BD07, tolterodine, Allopurinol may decrease the excretion rate of Tolterodine which could result in a higher serum level.]
[J01DH04, doripenem, Allopurinol may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[L03AB11, peginterferon alfa-2a, The risk or severity of adverse effects can be increased when Allopurinol is combined with Peginterferon alfa-2a.]
[L01FA01, rituximab, The risk or severity of adverse effects can be increased when Allopurinol is combined with Rituximab.]
[M01CB03, auranofin, Allopurinol may decrease the excretion rate of Auranofin which could result in a higher serum level.]
[L01XJ01, vismodegib, Vismodegib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[B03XA04, peginesatide, Allopurinol may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, The risk or severity of adverse effects can be increased when Allopurinol is combined with Azacitidine.]
[L04AX01, azathioprine, The serum concentration of Azathioprine can be increased when it is combined with Allopurinol.]
[L01BC05, gemcitabine, The risk or severity of adverse effects can be increased when Allopurinol is combined with Gemcitabine.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[G04BE10, avanafil, Avanafil may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[M03BX01, baclofen, Baclofen may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01FX02, gemtuzumab ozogamicin, The risk or severity of adverse effects can be increased when Allopurinol is combined with Gemtuzumab ozogamicin.]
[A08AA11, lorcaserin, Allopurinol may decrease the excretion rate of Lorcaserin which could result in a higher serum level.]
[G04BD12, mirabegron, Allopurinol may decrease the excretion rate of Mirabegron which could result in a higher serum level.]
[L01XG02, carfilzomib, The risk or severity of adverse effects can be increased when Allopurinol is combined with Carfilzomib.]
[V03AX03, cobicistat, Cobicistat may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L02BB04, enzalutamide, Allopurinol may decrease the excretion rate of Enzalutamide which could result in a higher serum level.]
[L01EA04, bosutinib, The risk or severity of adverse effects can be increased when Allopurinol is combined with Bosutinib.]
[L04AA31, teriflunomide, The excretion of Allopurinol can be decreased when combined with Teriflunomide.]
[A02AA05, magnesium silicate, The therapeutic efficacy of Allopurinol can be decreased when used in combination with Magnesium silicate.]
[A02AC02, calcium silicate, The therapeutic efficacy of Allopurinol can be decreased when used in combination with Calcium silicate.]
[L01EX05, regorafenib, Regorafenib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[D02BA02, octinoxate, Allopurinol may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[J05AE04, nelfinavir, Nelfinavir may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01AA09, bendamustine, The risk or severity of rash, hypersensitivity reaction, Stevens-Johnson syndrome, and Cutaneous drug reaction can be increased when Allopurinol is combined with Bendamustine.]
[N04BD02, rasagiline, Allopurinol may decrease the excretion rate of Rasagiline which could result in a higher serum level.]
[L04AA29, tofacitinib, The risk or severity of adverse effects can be increased when Allopurinol is combined with Tofacitinib.]
[V09IX04, fluorodeoxyglucose F18, Allopurinol may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[V08CA11, gadofosveset, Allopurinol may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[L01EA05, ponatinib, The risk or severity of adverse effects can be increased when Allopurinol is combined with Ponatinib.]
[A16AX08, teduglutide, Allopurinol may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[A10BH04, alogliptin, Allopurinol may decrease the excretion rate of Alogliptin which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, Allopurinol may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Bendroflumethiazide.]
[L04AX06, pomalidomide, The risk or severity of adverse effects can be increased when Allopurinol is combined with Pomalidomide.]
[N02BA10, benorilate, Benorilate may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[A10BK02, canagliflozin, Canagliflozin may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.]
[L03AA12, ancestim, Allopurinol may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, Celecoxib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L04AA18, everolimus, The risk or severity of adverse effects can be increased when Allopurinol is combined with Everolimus.]
[N04AC01, benztropine, Benzatropine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01EC02, dabrafenib, The excretion of Allopurinol can be decreased when combined with Dabrafenib.]
[R02AX03, benzydamine, Benzydamine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01EE01, trametinib, Allopurinol may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[V09AX05, florbetapir F-18, Allopurinol may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[L01EB03, afatinib, Afatinib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N06AX28, levomilnacipran, Allopurinol may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.]
[J05AJ03, dolutegravir, The excretion of Allopurinol can be decreased when combined with Dolutegravir.]
[A10BJ03, lixisenatide, Allopurinol may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[A05AA03, cholic acid, The excretion of Allopurinol can be decreased when combined with Cholic Acid.]
[C02KX04, macitentan, Allopurinol may decrease the excretion rate of Macitentan which could result in a higher serum level.]
[L01EL01, ibrutinib, The risk or severity of adverse effects can be increased when Allopurinol is combined with Ibrutinib.]
[N06AX26, vortioxetine, Allopurinol may decrease the excretion rate of Vortioxetine which could result in a higher serum level.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J05AP05, simeprevir, Simeprevir may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J05AP08, sofosbuvir, Allopurinol may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, Dapagliflozin may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Allopurinol may decrease the excretion rate of Droxidopa which could result in a higher serum level.]
[N05CH03, tasimelteon, Allopurinol may decrease the excretion rate of Tasimelteon which could result in a higher serum level.]
[L04AA32, apremilast, Allopurinol may decrease the excretion rate of Apremilast which could result in a higher serum level.]
[L02BG02, formestane, Allopurinol may decrease the excretion rate of Formestane which could result in a higher serum level.]
[V03AB34, fomepizole, Allopurinol may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[B01AA07, acenocoumarol, The risk or severity of bleeding can be increased when Allopurinol is combined with Acenocoumarol.]
[L01XH04, belinostat, The risk or severity of adverse effects can be increased when Allopurinol is combined with Belinostat.]
[N07XX08, tafamidis, The serum concentration of Allopurinol can be increased when it is combined with Tafamidis.]
[L03AB13, peginterferon beta-1a, The risk or severity of adverse effects can be increased when Allopurinol is combined with Peginterferon beta-1a.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01BC08, decitabine, The risk or severity of adverse effects can be increased when Allopurinol is combined with Decitabine.]
[S03AA06, gentamicin, Allopurinol may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[L01FX07, blinatumomab, The risk or severity of adverse effects can be increased when Allopurinol is combined with Blinatumomab.]
[J05AP09, dasabuvir, Dasabuvir may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01XK01, olaparib, The risk or severity of adverse effects can be increased when Allopurinol is combined with Olaparib.]
[B01AA01, dicumarol, The serum concentration of Dicoumarol can be increased when it is combined with Allopurinol.]
[B01AF03, edoxaban, Allopurinol may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[L01EF01, palbociclib, The risk or severity of adverse effects can be increased when Allopurinol is combined with Palbociclib.]
[L01EX08, lenvatinib, The excretion of Allopurinol can be decreased when combined with Lenvatinib.]
[J05AP07, daclatasvir, Daclatasvir may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N02BE01, acetaminophen, Acetaminophen may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01DC01, bleomycin, Bleomycin may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Allopurinol is combined with Tioclomarol.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[A04AD14, rolapitant, Rolapitant may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[A06AD03, magnesium peroxide, The therapeutic efficacy of Allopurinol can be decreased when used in combination with Magnesium peroxide.]
[M02AA25, aceclofenac, Aceclofenac may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[M01AB11, acemetacin, Acemetacin may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BC03, lansoprazole, The excretion of Allopurinol can be decreased when combined with Lansoprazole.]
[V03AB37, idarucizumab, Allopurinol may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[L01CX01, trabectedin, The risk or severity of adverse effects can be increased when Allopurinol is combined with Trabectedin.]
[J02AC05, isavuconazole, Isavuconazole may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01EB04, osimertinib, Osimertinib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Allopurinol.]
[L01XG03, ixazomib, Allopurinol may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[L01ED03, alectinib, Alectinib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J05AP10, elbasvir, Elbasvir may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J05AP11, grazoprevir, Grazoprevir may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[M01AE16, alminoprofen, Alminoprofen may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[A02AB06, aloglutamol, The therapeutic efficacy of Allopurinol can be decreased when used in combination with Aloglutamol.]
[N03AX23, brivaracetam, Allopurinol may decrease the excretion rate of Brivaracetam which could result in a higher serum level.]
[L01XX52, venetoclax, Venetoclax may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N05BA08, bromazepam, Allopurinol may decrease the excretion rate of Bromazepam which could result in a higher serum level.]
[A02AD05, aluminum magnesium silicate, The therapeutic efficacy of Allopurinol can be decreased when used in combination with Almasilate.]
[A02AB03, aluminum phosphate, The therapeutic efficacy of Allopurinol can be decreased when used in combination with Aluminium phosphate.]
[C03CA02, bumetanide, The risk or severity of adverse effects can be increased when Bumetanide is combined with Allopurinol.]
[N01BB01, bupivacaine, Allopurinol may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.]
[N07BC01, buprenorphine, Buprenorphine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N05BE01, buspirone, Allopurinol may decrease the excretion rate of Buspirone which could result in a higher serum level.]
[L01AB01, busulfan, The risk or severity of adverse effects can be increased when Allopurinol is combined with Busulfan.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Allopurinol is combined with Arsenic trioxide.]
[M02AA03, clofezone, Rabeprazole may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01XK03, rucaparib, Rucaparib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[A07EC04, balsalazide, Balsalazide may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[R03DA08, bamifylline, The serum concentration of Bamifylline can be increased when it is combined with Allopurinol.]
[A06AH05, naldemedine, Allopurinol may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Allopurinol may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, Pregabalin may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N06BC01, caffeine, The serum concentration of Caffeine can be increased when it is combined with Allopurinol.]
[C09AA07, benazepril, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Benazepril.]
[A12AA04, calcium carbonate, The therapeutic efficacy of Allopurinol can be decreased when used in combination with Calcium carbonate.]
[P01CA02, benznidazole, Allopurinol may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J01XX08, linezolid, The risk or severity of adverse effects can be increased when Allopurinol is combined with Linezolid.]
[J05AF06, abacavir, Allopurinol may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[N07XX13, valbenazine, Allopurinol may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[L01ED04, brigatinib, Brigatinib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N04BD03, safinamide, Safinamide may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J01MA23, delafloxacin, Allopurinol may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[L01BC06, capecitabine, The risk or severity of adverse effects can be increased when Allopurinol is combined with Capecitabine.]
[L01XX59, enasidenib, The excretion of Allopurinol can be decreased when combined with Enasidenib.]
[L01XH01, vorinostat, The risk or severity of adverse effects can be increased when Allopurinol is combined with Vorinostat.]
[L01EF03, abemaciclib, Abemaciclib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[A02BX12, bismuth subnitrate, The therapeutic efficacy of Allopurinol can be decreased when used in combination with Bismuth subnitrate.]
[C07AB07, bisoprolol, Allopurinol may decrease the excretion rate of Bisoprolol which could result in a higher serum level.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01BA03, raltitrexed, The risk or severity of adverse effects can be increased when Allopurinol is combined with Raltitrexed.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, Allopurinol may decrease the excretion rate of Budesonide which could result in a higher serum level.]
[M01AB07, bumadizone, Bumadizone may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J05AX18, letermovir, The excretion of Allopurinol can be decreased when combined with Letermovir.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AX18, acrivastine, Allopurinol may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[C09AA01, captopril, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Captopril.]
[L02BB05, apalutamide, The excretion of Allopurinol can be decreased when combined with Apalutamide.]
[N03AF01, carbamazepine, The risk or severity of Stevens-Johnson syndrome can be increased when Allopurinol is combined with Carbamazepine.]
[L03AB06, interferon alfa-n1, The risk or severity of adverse effects can be increased when Allopurinol is combined with Interferon alfa-n1.]
[B02BX09, fostamatinib, Fostamatinib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N03AX24, cannabidiol, Cannabidiol may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[B02BX08, avatrombopag, The excretion of Allopurinol can be decreased when combined with Avatrombopag.]
[L04AA37, baricitinib, Allopurinol may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J01DD14, ceftibuten, The excretion of Allopurinol can be decreased when combined with Ceftibuten.]
[J01GB14, plazomicin, Allopurinol may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[A16AX14, migalastat, Allopurinol may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, The excretion of Allopurinol can be decreased when combined with Stiripentol.]
[L01EB07, dacomitinib, Dacomitinib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[S01GX12, cetirizine, Cetirizine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[D08AE05, chloroxylenol, Allopurinol may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, Lornoxicam may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[R03DA02, oxtriphylline, The serum concentration of Oxtriphylline can be increased when it is combined with Allopurinol.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01AD01, carmustine, The risk or severity of adverse effects can be increased when Allopurinol is combined with Carmustine.]
[L01EX13, gilteritinib, Gilteritinib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01XJ03, glasdegib, Glasdegib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[A06AX05, prucalopride, Allopurinol may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C09AA08, cilazapril, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Cilazapril.]
[B01AC23, cilostazol, Allopurinol may decrease the excretion rate of Cilostazol which could result in a higher serum level.]
[N06BA14, solriamfetol, Allopurinol may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[N05BA09, clobazam, Clobazam may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J01DC04, cefaclor, The excretion of Allopurinol can be decreased when combined with Cefaclor.]
[J01DB05, cefadroxil, The excretion of Allopurinol can be decreased when combined with Cefadroxil.]
[J01DC03, cefamandole, The excretion of Allopurinol can be decreased when combined with Cefamandole.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J01DB04, cefazolin, The excretion of Allopurinol can be decreased when combined with Cefazolin.]
[L02BB06, darolutamide, The serum concentration of Allopurinol can be increased when it is combined with Darolutamide.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J01DD12, cefoperazone, The excretion of Allopurinol can be decreased when combined with Cefoperazone.]
[J01DD01, cefotaxime, The excretion of Allopurinol can be decreased when combined with Cefotaxime.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J01DC07, cefotiam, The excretion of Allopurinol can be decreased when combined with Cefotiam.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, The excretion of Allopurinol can be decreased when combined with Ceftizoxime.]
[J01DD04, ceftriaxone, The excretion of Allopurinol can be decreased when combined with Ceftriaxone.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01EJ02, fedratinib, Fedratinib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N07XX11, pitolisant, Allopurinol may decrease the excretion rate of Pitolisant which could result in a higher serum level.]
[N04CX01, istradefylline, Istradefylline may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C03AA09, cyclothiazide, The therapeutic efficacy of Allopurinol can be decreased when used in combination with Cyclothiazide.]
[J01XX09, daptomycin, Daptomycin may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J01DB01, cephalexin, The excretion of Allopurinol can be decreased when combined with Cephalexin.]
[J01DB02, cephaloridine, The excretion of Allopurinol can be decreased when combined with Cefaloridine.]
[J01DB03, cephalothin, The excretion of Allopurinol can be decreased when combined with Cefalotin.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01FD03, ado-trastuzumab emtansine, The risk or severity of adverse effects can be increased when Allopurinol is combined with Trastuzumab emtansine.]
[N02CC08, lasmiditan, The serum concentration of Allopurinol can be increased when it is combined with Lasmiditan.]
[A16AX16, givosiran, Givosiran may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[M09AX08, golodirsen, Allopurinol may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[S01XA12, dexpanthenol, Allopurinol may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[R02AA03, dichlorobenzyl alcohol, Allopurinol may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Allopurinol may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[M01AH02, rofecoxib, Rofecoxib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01XF03, bexarotene, The risk or severity of adverse effects can be increased when Allopurinol is combined with Bexarotene.]
[C08CA16, clevidipine, Allopurinol may decrease the excretion rate of Clevidipine which could result in a higher serum level.]
[C01BD07, dronedarone, The excretion of Allopurinol can be decreased when combined with Dronedarone.]
[L01AA02, chlorambucil, The risk or severity of adverse effects can be increased when Allopurinol is combined with Chlorambucil.]
[S03AA08, chloramphenicol, The risk or severity of adverse effects can be increased when Allopurinol is combined with Chloramphenicol.]
[L01EX17, capmatinib, The serum concentration of Allopurinol can be increased when it is combined with Capmatinib.]
[M01AC04, droxicam, Droxicam may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01EX19, ripretinib, Ripretinib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[V08CA05, mangafodipir, Allopurinol may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[M02AA27, dexketoprofen, Dexketoprofen may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J05AX29, fostemsavir, Fostemsavir may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[P01BA01, chloroquine, Allopurinol may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[L01EX23, pralsetinib, Pralsetinib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C03AA04, chlorothiazide, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Chlorothiazide.]
[N05AA01, chlorpromazine, Allopurinol may decrease the excretion rate of Chlorpromazine which could result in a higher serum level.]
[A10BB02, chlorpropamide, The excretion of Chlorpropamide can be decreased when combined with Allopurinol.]
[C03BA04, chlorthalidone, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Chlorthalidone.]
[M03BB03, chlorzoxazone, Chlorzoxazone may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N02BA07, ethenzamide, Ethenzamide may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N02BA03, choline salicylate, Allopurinol may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[M01AB08, etodolac, Etodolac may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[M02AA06, etofenamate, Etofenamate may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01BB05, fludarabine, The risk or severity of adverse effects can be increased when Allopurinol is combined with Fludarabine.]
[M01AX25, chondroitin sulfates, Allopurinol may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[J05AJ04, cabotegravir, The excretion of Allopurinol can be decreased when combined with Cabotegravir.]
[L01EX21, tepotinib, Tepotinib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[M01AE05, fenbufen, Fenbufen may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N06BA10, fenethylline, The serum concentration of Fenethylline can be increased when it is combined with Allopurinol.]
[C01CA19, fenoldopam, Allopurinol may decrease the excretion rate of Fenoldopam which could result in a higher serum level.]
[J01DD15, cefdinir, Allopurinol may decrease the excretion rate of Cefdinir which could result in a higher serum level.]
[S02BA08, fluocinolone acetonide, Allopurinol may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level.]
[N02BG07, flupirtine, Allopurinol may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[L01EK03, tivozanib, Tivozanib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L03AB10, peginterferon alfa-2b, The risk or severity of adverse effects can be increased when Allopurinol is combined with Peginterferon alfa-2b.]
[A02BA01, cimetidine, The excretion of Allopurinol can be decreased when combined with Cimetidine.]
[V08CA04, gadoteridol, Allopurinol may decrease the excretion rate of Gadoteridol which could result in a higher serum level.]
[L01XX73, sotorasib, The serum concentration of Allopurinol can be increased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, Allopurinol may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.]
[L01XA01, cisplatin, The risk or severity of adverse effects can be increased when Allopurinol is combined with Cisplatin.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AA48, belumosudil, Belumosudil may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[P01CA03, fexinidazole, The excretion of Allopurinol can be decreased when combined with Fexinidazole.]
[V09AB03, ioflupane I-123, Allopurinol may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Allopurinol may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Allopurinol may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[J05AX10, maribavir, Maribavir may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of adverse effects can be increased when Allopurinol is combined with Ropeginterferon alfa-2b.]
[J04BA01, clofazimine, Clofazimine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N01BB10, levobupivacaine, Allopurinol may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.]
[L01EJ03, pacritinib, The serum concentration of Allopurinol can be increased when it is combined with Pacritinib.]
[N06AA04, clomipramine, Allopurinol may decrease the excretion rate of Clomipramine which could result in a higher serum level.]
[N03AE01, clonazepam, Allopurinol may decrease the excretion rate of Clonazepam which could result in a higher serum level.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J02AC06, oteseconazole, The serum concentration of Allopurinol can be increased when it is combined with Oteseconazole.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AH02, clozapine, Clozapine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[A10BK06, sotagliflozin, Sotagliflozin may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J01GB12, arbekacin, Allopurinol may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[M01AX13, proquazone, Proquazone may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[M04AC01, colchicine, Allopurinol may decrease the excretion rate of Colchicine which could result in a higher serum level.]
[J01XB01, colistin, Allopurinol may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[A02AD04, hydrotalcite, The therapeutic efficacy of Allopurinol can be decreased when used in combination with Hydrotalcite.]
[A04AA03, tropisetron, Allopurinol may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[A10BX03, nateglinide, Allopurinol may decrease the excretion rate of Nateglinide which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01BB07, nelarabine, The risk or severity of adverse effects can be increased when Allopurinol is combined with Nelarabine.]
[B01AC10, indobufen, Indobufen may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J05AB14, valganciclovir, Allopurinol may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Allopurinol may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Allopurinol may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Allopurinol may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Allopurinol may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Allopurinol may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, Valdecoxib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N02CC05, almotriptan, Allopurinol may decrease the excretion rate of Almotriptan which could result in a higher serum level.]
[M01AH04, parecoxib, Parecoxib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J02AC02, itraconazole, Itraconazole may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[S01AD03, acyclovir, The excretion of Allopurinol can be decreased when combined with Acyclovir.]
[N05BA10, ketazolam, Allopurinol may decrease the excretion rate of Ketazolam which could result in a higher serum level.]
[M01AA06, kebuzone, Kebuzone may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01EA01, imatinib, The risk or severity of adverse effects can be increased when Allopurinol is combined with Imatinib.]
[A02BC05, esomeprazole, The excretion of Allopurinol can be decreased when combined with Esomeprazole.]
[N03AX09, lamotrigine, Allopurinol may decrease the excretion rate of Lamotrigine which could result in a higher serum level.]
[N07BC04, lofexidine, Allopurinol may decrease the excretion rate of Lofexidine which could result in a higher serum level.]
[M01AB09, lonazolac, Lonazolac may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[M02AA31, loxoprofen, Loxoprofen may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C09AA03, lisinopril, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Lisinopril.]
[A02AD02, magaldrate, The therapeutic efficacy of Allopurinol can be decreased when used in combination with Magaldrate.]
[A06AD01, magnesium carbonate, The therapeutic efficacy of Allopurinol can be decreased when used in combination with Magnesium carbonate.]
[J01DH02, meropenem, Allopurinol may decrease the excretion rate of Meropenem which could result in a higher serum level.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, Allopurinol may decrease the excretion rate of Melperone which could result in a higher serum level.]
[C03AA07, cyclopenthiazide, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Cyclopenthiazide.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01AA01, cyclophosphamide, The risk or severity of adverse effects can be increased when Allopurinol is combined with Cyclophosphamide.]
[S01XA18, cyclosporine, The serum concentration of Cyclosporine can be increased when it is combined with Allopurinol.]
[C09AA13, moexipril, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Moexipril.]
[C10AA07, rosuvastatin, The excretion of Allopurinol can be decreased when combined with Rosuvastatin.]
[M02AA02, mofebutazone, Mofebutazone may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[M01AX22, morniflumate, Morniflumate may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C03XA02, conivaptan, Conivaptan may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Allopurinol is combined with Cytarabine.]
[M01AH05, etoricoxib, Etoricoxib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01AX04, dacarbazine, The risk or severity of adverse effects can be increased when Allopurinol is combined with Dacarbazine.]
[L01DA01, dactinomycin, The risk or severity of adverse effects can be increased when Allopurinol is combined with Dactinomycin.]
[L01DB02, daunorubicin, The risk or severity of adverse effects can be increased when Allopurinol is combined with Daunorubicin.]
[M01AX01, nabumetone, Nabumetone may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N07BB05, nalmefene, Allopurinol may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[S01GX04, nedocromil, Allopurinol may decrease the excretion rate of Nedocromil which could result in a higher serum level.]
[N06AX06, nefazodone, Allopurinol may decrease the excretion rate of Nefazodone which could result in a higher serum level.]
[C01DX16, nicorandil, Allopurinol may decrease the excretion rate of Nicorandil which could result in a higher serum level.]
[L02BB02, nilutamide, Allopurinol may decrease the excretion rate of Nilutamide which could result in a higher serum level.]
[C01CA23, theodrenaline, The serum concentration of Theodrenaline can be increased when it is combined with Allopurinol.]
[B01AX05, fondaparinux, Allopurinol may decrease the excretion rate of Fondaparinux which could result in a higher serum level.]
[A07EC03, olsalazine, Olsalazine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N06AA01, desipramine, Allopurinol may decrease the excretion rate of Desipramine which could result in a higher serum level.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[V04CH02, indigo carmine, Allopurinol may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01XA03, oxaliplatin, The risk or severity of adverse effects can be increased when Allopurinol is combined with Oxaliplatin.]
[M01AE12, oxaprozin, Oxaprozin may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[S03BA01, dexamethasone, Dexamethasone may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01EB01, gefitinib, Gefitinib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C04AD01, pentifylline, The serum concentration of Pentifylline can be increased when it is combined with Allopurinol.]
[P03AC04, permethrin, Allopurinol may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, Allopurinol may decrease the excretion rate of Diazepam which could result in a higher serum level.]
[R05DA08, pholcodine, Allopurinol may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, The excretion of Allopurinol can be decreased when combined with Diclofenac.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[A03AA07, dicyclomine, Allopurinol may decrease the excretion rate of Dicyclomine which could result in a higher serum level.]
[J05AF02, didanosine, The serum concentration of Didanosine can be increased when it is combined with Allopurinol.]
[L01DC04, ixabepilone, The risk or severity of adverse effects can be increased when Allopurinol is combined with Ixabepilone.]
[L01EB02, erlotinib, Erlotinib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C03CA03, piretanide, The risk or severity of adverse effects can be increased when Piretanide is combined with Allopurinol.]
[L02AA01, diethylstilbestrol, Diethylstilbestrol may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C08CA03, isradipine, Isradipine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[D07XC04, diflucortolone, Allopurinol may decrease the excretion rate of Difluocortolone which could result in a higher serum level.]
[N02BA11, diflunisal, Diflunisal may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C01AA05, digoxin, Allopurinol may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[N02AA03, hydromorphone, Hydromorphone may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L04AX04, lenalidomide, The risk or severity of adverse effects can be increased when Allopurinol is combined with Lenalidomide.]
[J05AE08, atazanavir, Atazanavir may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[H03BC01, potassium perchlorate, Allopurinol may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Allopurinol may decrease the excretion rate of Pralidoxime which could result in a higher serum level.]
[V03AB09, dimercaprol, Allopurinol may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[M02AX03, dimethyl sulfoxide, Allopurinol may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.]
[N06BC02, propentofylline, The serum concentration of Propentofylline can be increased when it is combined with Allopurinol.]
[N02BB04, propyphenazone, Propyphenazone may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[M01AB14, proglumetacin, Proglumetacin may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[G02AD02, dinoprostone, The excretion of Allopurinol can be decreased when combined with Dinoprostone.]
[R03DA03, proxyphylline, The serum concentration of Proxyphylline can be increased when it is combined with Allopurinol.]
[C09AA06, quinapril, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Quinapril.]
[C09AA05, ramipril, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Ramipril.]
[S01XA23, sirolimus, The risk or severity of adverse effects can be increased when Allopurinol is combined with Sirolimus.]
[S01AX06, resorcinol, Allopurinol may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, Disopyramide may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[R06AE09, levocetirizine, Allopurinol may decrease the excretion rate of Levocetirizine which could result in a higher serum level.]
[N01BB09, ropivacaine, Ropivacaine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01EX01, sunitinib, Sunitinib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C03XA01, tolvaptan, Tolvaptan may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XG01, bortezomib, The risk or severity of adverse effects can be increased when Allopurinol is combined with Bortezomib.]
[G04BE08, tadalafil, Allopurinol may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[S01BC05, ketorolac, Ketorolac may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C01EB18, ranolazine, Ranolazine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N02BA06, salsalate, Salsalate may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C01CA07, dobutamine, Allopurinol may decrease the excretion rate of Dobutamine which could result in a higher serum level.]
[C01CA04, dopamine, Allopurinol may decrease the excretion rate of Dopamine which could result in a higher serum level.]
[N06AA12, doxepin, Allopurinol may decrease the excretion rate of Doxepin which could result in a higher serum level.]
[L01DB01, doxorubicin, The risk or severity of adverse effects can be increased when Allopurinol is combined with Doxorubicin.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[A08AA10, sibutramine, Allopurinol may decrease the excretion rate of Sibutramine which could result in a higher serum level.]
[B05XA02, sodium bicarbonate, The therapeutic efficacy of Allopurinol can be decreased when used in combination with Sodium bicarbonate.]
[A12CA02, sodium sulfate, Allopurinol may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[C09AA11, spirapril, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Spirapril.]
[R03DA01, dyphylline, The serum concentration of Dyphylline can be increased when it is combined with Allopurinol.]
[N02CC01, sumatriptan, Allopurinol may decrease the excretion rate of Sumatriptan which could result in a higher serum level.]
[V04CX07, edrophonium, Allopurinol may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[J01CG02, tazobactam, The excretion of Allopurinol can be decreased when combined with Tazobactam.]
[L01AX03, temozolomide, The risk or severity of adverse effects can be increased when Allopurinol is combined with Temozolomide.]
[M01AC02, tenoxicam, The excretion of Allopurinol can be decreased when combined with Tenoxicam.]
[C09AA02, enalapril, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Enalapril.]
[M01AG02, tolfenamic acid, Tolfenamic acid may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N06AG03, toloxatone, Allopurinol may decrease the excretion rate of Toloxatone which could result in a higher serum level.]
[N06BA09, atomoxetine, Atomoxetine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N03AX11, topiramate, Topiramate may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C03CA04, torsemide, The risk or severity of adverse effects can be increased when Torasemide is combined with Allopurinol.]
[C09AA10, trandolapril, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Trandolapril.]
[N05CC01, chloral hydrate, Allopurinol may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[L01CA04, vinorelbine, The risk or severity of adverse effects can be increased when Allopurinol is combined with Vinorelbine.]
[N06AX16, venlafaxine, Venlafaxine may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.]
[L01DB03, epirubicin, The risk or severity of adverse effects can be increased when Allopurinol is combined with Epirubicin.]
[C09AA15, zofenopril, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Zofenopril.]
[M01AB04, zomepirac, Zomepirac may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N03AX15, zonisamide, Zonisamide may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XA02, carboplatin, The risk or severity of adverse effects can be increased when Allopurinol is combined with Carboplatin.]
[C02AC02, guanfacine, Allopurinol may decrease the excretion rate of Guanfacine which could result in a higher serum level.]
[N03AG01, valproic acid, The excretion of Allopurinol can be decreased when combined with Valproic acid.]
[L03AX05, pidotimod, Allopurinol may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[N05CD04, estazolam, Allopurinol may decrease the excretion rate of Estazolam which could result in a higher serum level.]
[A02BC02, pantoprazole, The excretion of Allopurinol can be decreased when combined with Pantoprazole.]
[G03CA03, estradiol, Estradiol may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Allopurinol can be decreased when combined with Conjugated estrogens.]
[J04AK02, ethambutol, Ethambutol may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[M01AC06, meloxicam, Meloxicam may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N01AX07, etomidate, Etomidate may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01CB01, etoposide, The risk or severity of adverse effects can be increased when Allopurinol is combined with Etoposide.]
[L04AD02, tacrolimus, The risk or severity of adverse effects can be increased when Allopurinol is combined with Tacrolimus.]
[P01AX07, trimetrexate, Allopurinol may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, Allopurinol may decrease the excretion rate of Bupropion which could result in a higher serum level.]
[N06AB08, fluvoxamine, Fluvoxamine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L02AE02, leuprolide, Leuprolide may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C10AA03, pravastatin, The excretion of Allopurinol can be decreased when combined with Pravastatin.]
[M01CB01, gold sodium thiomalate, Allopurinol may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[B05AA05, dextran, Allopurinol may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, The risk or severity of adverse effects can be increased when Allopurinol is combined with Dexrazoxane.]
[A02BA03, famotidine, The excretion of Allopurinol can be decreased when combined with Famotidine.]
[A16AA01, levocarnitine, Allopurinol may decrease the excretion rate of Levocarnitine which could result in a higher serum level.]
[M01AE04, fenoprofen, Fenoprofen may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N02AB03, fentanyl, Allopurinol may decrease the excretion rate of Fentanyl which could result in a higher serum level.]
[R03CC02, albuterol, Allopurinol may decrease the excretion rate of Salbutamol which could result in a higher serum level.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Allopurinol is combined with Clofarabine.]
[L04AA40, cladribine, The risk or severity of adverse effects can be increased when Allopurinol is combined with Cladribine.]
[N07AX03, cevimeline, Cevimeline may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[G04BD02, flavoxate, Allopurinol may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[N02BG04, floctafenine, Floctafenine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J02AC01, fluconazole, Fluconazole may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J02AX01, flucytosine, The risk or severity of adverse effects can be increased when Allopurinol is combined with Flucytosine.]
[V03AB25, flumazenil, Allopurinol may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[L01BC09, floxuridine, The risk or severity of adverse effects can be increased when Allopurinol is combined with Floxuridine.]
[L01BC02, fluorouracil, The risk or severity of adverse effects can be increased when Allopurinol is combined with Fluorouracil.]
[N05CD01, flurazepam, Allopurinol may decrease the excretion rate of Flurazepam which could result in a higher serum level.]
[S01BC04, flurbiprofen, Flurbiprofen may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L02BB01, flutamide, Allopurinol may decrease the excretion rate of Flutamide which could result in a higher serum level.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[S02AA17, fosfomycin, Allopurinol may decrease the excretion rate of Fosfomycin which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01BC03, tegafur, Allopurinol may decrease the excretion rate of Tegafur which could result in a higher serum level.]
[C03CA01, furosemide, The risk or severity of adverse effects can be increased when Furosemide is combined with Allopurinol.]
[N05CF04, eszopiclone, Eszopiclone may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[S01AD09, ganciclovir, The excretion of Allopurinol can be decreased when combined with Ganciclovir.]
[C10AB04, gemfibrozil, The excretion of Allopurinol can be decreased when combined with Gemfibrozil.]
[J01XA03, telavancin, Allopurinol may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01EA02, dasatinib, The risk or severity of adverse effects can be increased when Allopurinol is combined with Dasatinib.]
[C01CA21, cafedrine, The serum concentration of Cafedrine can be increased when it is combined with Allopurinol.]
[A10BB07, glipizide, Allopurinol may decrease the excretion rate of Glipizide which could result in a higher serum level.]
[N05CM18, dexmedetomidine, Allopurinol may decrease the excretion rate of Dexmedetomidine which could result in a higher serum level.]
[L01EX02, sorafenib, The risk or severity of adverse effects can be increased when Allopurinol is combined with Sorafenib.]
[M01CB04, aurothioglucose, Allopurinol may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Allopurinol may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[B01AA12, fluindione, The risk or severity of bleeding can be increased when Allopurinol is combined with Fluindione.]
[C09AA09, fosinopril, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Fosinopril.]
[S01EX01, guanethidine, Allopurinol may decrease the excretion rate of Guanethidine which could result in a higher serum level.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N05AD01, haloperidol, Allopurinol may decrease the excretion rate of Haloperidol which could result in a higher serum level.]
[N05AH04, quetiapine, Allopurinol may decrease the excretion rate of Quetiapine which could result in a higher serum level.]
[N06BX13, idebenone, Allopurinol may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[L01CE02, irinotecan, The risk or severity of adverse effects can be increased when Allopurinol is combined with Irinotecan.]
[M01AG01, mefenamic acid, Mefenamic acid may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C01DA05, pentaerythritol tetranitrate, Allopurinol may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[G03DC01, allylestrenol, Allopurinol may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[A07EC02, mesalamine, Mesalazine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01XX03, altretamine, The risk or severity of adverse effects can be increased when Allopurinol is combined with Altretamine.]
[M02AA26, nimesulide, Nimesulide may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C09AA04, perindopril, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Perindopril.]
[C02DB02, hydralazine, Allopurinol may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C03AA03, hydrochlorothiazide, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Hydrochlorothiazide.]
[C03AA02, hydroflumethiazide, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Hydroflumethiazide.]
[B05XA17, potassium acetate, Allopurinol may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[G04BD06, propiverine, Allopurinol may decrease the excretion rate of Propiverine which could result in a higher serum level.]
[B05AA07, hetastarch, Allopurinol may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[L01XX05, hydroxyurea, The risk or severity of adverse effects can be increased when Allopurinol is combined with Hydroxyurea.]
[R02AX02, ibuprofen, The excretion of Allopurinol can be decreased when combined with Ibuprofen.]
[B05XA08, sodium acetate, Allopurinol may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[L01DB06, idarubicin, The risk or severity of adverse effects can be increased when Allopurinol is combined with Idarubicin.]
[L01AA06, ifosfamide, The risk or severity of adverse effects can be increased when Allopurinol is combined with Ifosfamide.]
[N06AA02, imipramine, Allopurinol may decrease the excretion rate of Imipramine which could result in a higher serum level.]
[L01CD01, paclitaxel, The risk or severity of adverse effects can be increased when Allopurinol is combined with Paclitaxel.]
[R01AD07, tixocortol, Allopurinol may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[L01CE01, topotecan, The risk or severity of adverse effects can be increased when Allopurinol is combined with Topotecan.]
[C03BA11, indapamide, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Indapamide.]
[S01BC01, indomethacin, The risk or severity of adverse effects can be increased when Allopurinol is combined with Indomethacin.]
[A11HA07, inositol, Allopurinol may decrease the excretion rate of Inositol which could result in a higher serum level.]
[L03AB04, interferon alfa-2a, The risk or severity of adverse effects can be increased when Allopurinol is combined with Interferon alfa-2a.]
[L03AB05, interferon alfa-2b, The risk or severity of adverse effects can be increased when Allopurinol is combined with Interferon alfa-2b.]
[N06AX17, milnacipran, Allopurinol may decrease the excretion rate of Milnacipran which could result in a higher serum level.]
[S01XA28, varenicline, Allopurinol may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[A10BH01, sitagliptin, Allopurinol may decrease the excretion rate of Sitagliptin which could result in a higher serum level.]
[N05BA12, alprazolam, Alprazolam may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N05CH02, ramelteon, Allopurinol may decrease the excretion rate of Ramelteon which could result in a higher serum level.]
[C03BA02, quinethazone, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Quinethazone.]
[L03AB09, interferon alfacon-1, The risk or severity of adverse effects can be increased when Allopurinol is combined with Interferon alfacon-1.]
[V03AB01, ipecac, Allopurinol may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[C09AA16, imidapril, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Imidapril.]
[J04AC01, isoniazid, Allopurinol may decrease the excretion rate of Isoniazid which could result in a higher serum level.]
[J05AX05, inosine pranobex, Allopurinol may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[D10BA01, isotretinoin, Allopurinol may decrease the excretion rate of Isotretinoin which could result in a higher serum level.]
[S01AA24, kanamycin, Allopurinol may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[A02AB01, aluminum hydroxide, The therapeutic efficacy of Allopurinol can be decreased when used in combination with Aluminum hydroxide.]
[N01AX03, ketamine, Allopurinol may decrease the excretion rate of Ketamine which could result in a higher serum level.]
[B01AC22, prasugrel, Allopurinol may decrease the excretion rate of Prasugrel which could result in a higher serum level.]
[M02AA10, ketoprofen, The excretion of Allopurinol can be decreased when combined with Ketoprofen.]
[C07AG01, labetalol, Allopurinol may decrease the excretion rate of Labetalol which could result in a higher serum level.]
[N04BB01, amantadine, Allopurinol may decrease the excretion rate of Amantadine which could result in a higher serum level.]
[A06AX03, lubiprostone, Allopurinol may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[L01DC03, mitomycin, The risk or severity of adverse effects can be increased when Allopurinol is combined with Mitomycin.]
[S01AA21, amikacin, Allopurinol may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.]
[L01AD02, lomustine, The risk or severity of adverse effects can be increased when Allopurinol is combined with Lomustine.]
[N05BA06, lorazepam, Lorazepam may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01EG01, temsirolimus, The risk or severity of adverse effects can be increased when Allopurinol is combined with Temsirolimus.]
[B05XA11, magnesium chloride, Allopurinol may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, The therapeutic efficacy of Allopurinol can be decreased when used in combination with Magnesium hydroxide.]
[A12CC10, magnesium oxide, The therapeutic efficacy of Allopurinol can be decreased when used in combination with Magnesium oxide.]
[L01BA05, pralatrexate, Allopurinol may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, The risk or severity of adverse effects can be increased when Allopurinol is combined with Nilotinib.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, Allopurinol may decrease the excretion rate of Maprotiline which could result in a higher serum level.]
[C02BB01, mecamylamine, Allopurinol may decrease the excretion rate of Mecamylamine which could result in a higher serum level.]
[L01AA05, mechlorethamine, The risk or severity of adverse effects can be increased when Allopurinol is combined with Mechlorethamine.]
[M02AA18, meclofenamic acid, Meclofenamic acid may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CH01, melatonin, The excretion of Allopurinol can be decreased when combined with Melatonin.]
[L01AA03, melphalan, The risk or severity of adverse effects can be increased when Allopurinol is combined with Melphalan.]
[N06DX01, memantine, Allopurinol may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AB02, meperidine, Allopurinol may decrease the excretion rate of Meperidine which could result in a higher serum level.]
[N01BB03, mepivacaine, Allopurinol may decrease the excretion rate of Mepivacaine which could result in a higher serum level.]
[G04BX16, tiopronin, Allopurinol may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX13, paliperidone, Allopurinol may decrease the excretion rate of Paliperidone which could result in a higher serum level.]
[A10BA02, metformin, Metformin may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N07BC02, methadone, Methadone may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N06BA03, methamphetamine, Allopurinol may decrease the excretion rate of Metamfetamine which could result in a higher serum level.]
[J05AF05, lamivudine, Allopurinol may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BB02, methimazole, The risk or severity of adverse effects can be increased when Allopurinol is combined with Methimazole.]
[L01BA04, pemetrexed, The risk or severity of adverse effects can be increased when Allopurinol is combined with Pemetrexed.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L04AX03, methotrexate, The risk or severity of adverse effects can be increased when Allopurinol is combined with Methotrexate.]
[D05BA02, methoxsalen, Allopurinol may decrease the excretion rate of Methoxsalen which could result in a higher serum level.]
[C03AA08, methyclothiazide, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Methyclothiazide.]
[C02AB01, methyldopa, Allopurinol may decrease the excretion rate of Methyldopa which could result in a higher serum level.]
[V04CG05, methylene blue, Allopurinol may decrease the excretion rate of Methylene blue which could result in a higher serum level.]
[R03DA05, aminophylline, The serum concentration of Aminophylline can be increased when it is combined with Allopurinol.]
[G03EK01, methyltestosterone, The excretion of Allopurinol can be increased when combined with Methyltestosterone.]
[A03FA01, metoclopramide, Allopurinol may decrease the excretion rate of Metoclopramide which could result in a higher serum level.]
[C03BA08, metolazone, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Metolazone.]
[C07AB02, metoprolol, Metoprolol may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[V04CD01, metyrapone, Allopurinol may decrease the excretion rate of Metyrapone which could result in a higher serum level.]
[N02BB03, aminopyrine, Aminophenazone may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N05CD08, midazolam, Allopurinol may decrease the excretion rate of Midazolam which could result in a higher serum level.]
[J05AH01, zanamivir, Allopurinol may decrease the excretion rate of Zanamivir which could result in a higher serum level.]
[J01AA08, minocycline, The excretion of Allopurinol can be decreased when combined with Minocycline.]
[L01DB07, mitoxantrone, The risk or severity of adverse effects can be increased when Allopurinol is combined with Mitoxantrone.]
[L03AC01, aldesleukin, The risk or severity of adverse effects can be increased when Allopurinol is combined with Aldesleukin.]
[N06AA09, amitriptyline, Amitriptyline may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[A04AA05, palonosetron, Palonosetron may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L04AB05, certolizumab pegol, Allopurinol may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.]
[B02BX05, eltrombopag, Eltrombopag may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[G04BA01, ammonium chloride, Allopurinol may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L04AA06, mycophenolic acid, Allopurinol may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.]
[N03AB05, fosphenytoin, The metabolism of Fosphenytoin can be decreased when combined with Allopurinol.]
[L03AB08, interferon beta-1b, The risk or severity of adverse effects can be increased when Allopurinol is combined with Interferon beta-1b.]
[C07AA12, nadolol, Allopurinol may decrease the excretion rate of Nadolol which could result in a higher serum level.]
[J01CA04, amoxicillin, The risk of a hypersensitivity reaction to Amoxicillin is increased when it is combined with Allopurinol.]
[V03AB15, naloxone, Allopurinol may decrease the excretion rate of Naloxone which could result in a higher serum level.]
[N06BA01, amphetamine, Amphetamine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[M02AA12, naproxen, Naproxen may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N06AX21, duloxetine, Allopurinol may decrease the excretion rate of Duloxetine which could result in a higher serum level.]
[N04BX01, tolcapone, Tolcapone may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01CD02, docetaxel, The risk or severity of adverse effects can be increased when Allopurinol is combined with Docetaxel.]
[S03AA01, neomycin, Allopurinol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[B01AC17, tirofiban, Allopurinol may decrease the excretion rate of Tirofiban which could result in a higher serum level.]
[J02AA01, amphotericin B, Amphotericin B may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[S01AA19, ampicillin, The risk of a hypersensitivity reaction to Ampicillin is increased when it is combined with Allopurinol.]
[L03AX16, plerixafor, Allopurinol may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Allopurinol may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, Allopurinol may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.]
[C09CA07, telmisartan, Telmisartan may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[M04AA03, febuxostat, The excretion of Allopurinol can be decreased when combined with Febuxostat.]
[C01CE01, inamrinone, Allopurinol may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[L01XX01, amsacrine, The risk or severity of adverse effects can be increased when Allopurinol is combined with Amsacrine.]
[C08CA05, nifedipine, Allopurinol may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[M02AA17, niflumic acid, Niflumic acid may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C08CA07, nisoldipine, Nisoldipine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[R07AX01, nitric oxide, Nitric Oxide may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J01XE01, nitrofurantoin, The serum concentration of Nitrofurantoin can be increased when it is combined with Allopurinol.]
[N05CF03, zaleplon, Allopurinol may decrease the excretion rate of Zaleplon which could result in a higher serum level.]
[N04BC05, pramipexole, Pramipexole may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C02DD01, nitroprusside, Nitroprusside may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[A02BC01, omeprazole, Omeprazole may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N02AA02, opium, Allopurinol may decrease the excretion rate of Opium which could result in a higher serum level.]
[G04CA02, tamsulosin, Allopurinol may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C01AC01, ouabain, The excretion of Allopurinol can be decreased when combined with Ouabain.]
[J01CF04, oxacillin, Allopurinol may decrease the excretion rate of Oxacillin which could result in a higher serum level.]
[N05BA04, oxazepam, Allopurinol may decrease the excretion rate of Oxazepam which could result in a higher serum level.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[S01AA04, oxytetracycline, The excretion of Allopurinol can be decreased when combined with Oxytetracycline.]
[V04CH30, 4-aminohippuric acid, The excretion of Allopurinol can be decreased when combined with Aminohippuric acid.]
[J04AB30, capreomycin, Allopurinol may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[G04BD11, fesoterodine, Allopurinol may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[C07AA23, penbutolol, Allopurinol may decrease the excretion rate of Penbutolol which could result in a higher serum level.]
[M01CC01, penicillamine, The risk or severity of adverse effects can be increased when Allopurinol is combined with Penicillamine.]
[S01AA14, penicillin G, The excretion of Allopurinol can be decreased when combined with Benzylpenicillin.]
[J01CE09, penicillin G procaine, Allopurinol may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N05CA01, pentobarbital, Pentobarbital may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01XX08, pentostatin, The risk or severity of adverse effects can be increased when Allopurinol is combined with Pentostatin.]
[C04AD03, pentoxifylline, The serum concentration of Pentoxifylline can be increased when it is combined with Allopurinol.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N06AF03, phenelzine, Allopurinol may decrease the excretion rate of Phenelzine which could result in a higher serum level.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Allopurinol is combined with Phenindione.]
[B01AA04, phenprocoumon, The risk or severity of bleeding can be increased when Allopurinol is combined with Phenprocoumon.]
[V03AB36, phentolamine, Allopurinol may decrease the excretion rate of Phentolamine which could result in a higher serum level.]
[M02AA01, phenylbutazone, The excretion of Allopurinol can be decreased when combined with Phenylbutazone.]
[N03AB02, phenytoin, The metabolism of Phenytoin can be decreased when combined with Allopurinol.]
[S01AE05, levofloxacin, Allopurinol may decrease the excretion rate of Levofloxacin which could result in a higher serum level.]
[B02BA01, vitamin K1, Allopurinol may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C07AA03, pindolol, Allopurinol may decrease the excretion rate of Pindolol which could result in a higher serum level.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J05AE01, saquinavir, Saquinavir may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N06BX03, piracetam, Allopurinol may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[S01BC06, piroxicam, The excretion of Allopurinol can be decreased when combined with Piroxicam.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[A10BG02, rosiglitazone, Rosiglitazone may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C03AA05, polythiazide, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Polythiazide.]
[J05AE03, ritonavir, Ritonavir may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[A10BH03, saxagliptin, Allopurinol may decrease the excretion rate of Saxagliptin which could result in a higher serum level.]
[B05XA01, potassium chloride, Allopurinol may decrease the excretion rate of Potassium chloride which could result in a higher serum level.]
[H02AB07, prednisone, Allopurinol may decrease the excretion rate of Prednisone which could result in a higher serum level.]
[M04AB01, probenecid, The excretion of Probenecid can be increased when combined with Allopurinol.]
[C01BA02, procainamide, Allopurinol may decrease the excretion rate of Procainamide which could result in a higher serum level.]
[L01XB01, procarbazine, The risk or severity of adverse effects can be increased when Allopurinol is combined with Procarbazine.]
[C10AB05, fenofibrate, Allopurinol may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[G03DA04, progesterone, Progesterone may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[R06AD02, promethazine, Allopurinol may decrease the excretion rate of Promethazine which could result in a higher serum level.]
[A03AB05, propantheline, Allopurinol may decrease the excretion rate of Propantheline which could result in a higher serum level.]
[C07AA05, propranolol, Allopurinol may decrease the excretion rate of Propranolol which could result in a higher serum level.]
[H03BA02, propylthiouracil, The risk or severity of adverse effects can be increased when Allopurinol is combined with Propylthiouracil.]
[N02CC04, rizatriptan, Allopurinol may decrease the excretion rate of Rizatriptan which could result in a higher serum level.]
[B01AC09, epoprostenol, Allopurinol may decrease the excretion rate of Epoprostenol which could result in a higher serum level.]
[N07XX07, dalfampridine, Allopurinol may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, Allopurinol may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C01BA01, quinidine, Allopurinol may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A02BA02, ranitidine, Allopurinol may decrease the excretion rate of Ranitidine which could result in a higher serum level.]
[C02AA01, rescinnamine, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Rescinnamine.]
[C02AA02, reserpine, Reserpine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[J05AP01, ribavirin, Allopurinol may decrease the excretion rate of Ribavirin which could result in a higher serum level.]
[J04AB02, rifampin, The excretion of Allopurinol can be decreased when combined with Rifampicin.]
[N02BA05, salicylamide, Salicylamide may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[A07EC01, sulfasalazine, Sulfasalazine may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[S01BC08, salicylic acid, The excretion of Allopurinol can be decreased when combined with Salicylic acid.]
[N05CA06, secobarbital, Secobarbital may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Allopurinol is combined with Obinutuzumab.]
[J01GB08, sisomicin, Allopurinol may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Allopurinol may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, Allopurinol may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[L01CD04, cabazitaxel, The risk or severity of adverse effects can be increased when Allopurinol is combined with Cabazitaxel.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.]
[C01DA14, isosorbide mononitrate, Allopurinol may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[D10AX03, azelaic acid, Allopurinol may decrease the excretion rate of Azelaic acid which could result in a higher serum level.]
[M01AE11, tiaprofenic acid, Tiaprofenic acid may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C03CC01, ethacrynic acid, The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Allopurinol.]
